首页 > 最新文献

Annals of Nutrition and Metabolism最新文献

英文 中文
Metabolomic Markers for Dietary Carbohydrate, Fat, and Protein Consumption: A Two-Sample Mendelian Randomization Study. 饮食碳水化合物、脂肪和蛋白质消耗的代谢组学标记:一项双样本孟德尔随机研究。
IF 2.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-03 DOI: 10.1159/000548523
Tung Hoang, Jeongseon Kim

Introduction: Observational studies have raised questions regarding the comprehensive metabolomic markers associated with dietary macronutrient intake. This study aimed to identify metabolites that are causally linked to dietary macronutrient consumption using a robust analytical framework.

Methods: This genetic association study employed a two-sample Mendelian randomization (MR) approach. Genetic proxies for metabolites and their summary statistics were sourced from 64 genome-wide association studies, and a meta-analysis provided summary statistics for 3,362 metabolites. Summary statistics for dietary carbohydrate, fat, and protein intakes were obtained from the UK Biobank. MR associations were assessed using inverse-variance weighted, weighted median, and Egger's regression models to enhance robustness. Significant metabolites were subjected to enrichment analysis to identify relevant metabolic pathways. Associations were expressed as odds ratios with 95% confidence intervals, and enrichment analysis was used to identify key KEGG pathways based on p values.

Results: MR analysis identified 540 metabolite-macronutrient associations: 186 for carbohydrate intake, 217 for fat intake, and 137 for protein intake. Metabolites inversely associated with carbohydrate and protein intake, but positively linked to fat intake, were enriched in KEGG pathways, particularly those governing the biosynthesis and metabolism of aromatic amino acids (tryptophan and phenylalanine) and branched-chain amino acids (BCAAs) (tyrosine, valine, leucine, and isoleucine).

Conclusion: This study comprehensively mapped the metabolite associations with dietary macronutrient intake using extensive genetic data. These findings highlight the critical roles of aromatic and BCAA biosynthesis and metabolism as key metabolic pathways in macronutrient regulation.

导论:观察性研究提出了与膳食宏量营养素摄入相关的综合代谢组学指标的问题。本研究旨在通过一个强大的分析框架确定与饮食宏量营养素消耗有因果关系的代谢物。方法:本遗传关联研究采用双样本孟德尔随机化方法。代谢物的遗传代理及其汇总统计数据来自64项全基因组关联研究,并对3,362种代谢物进行了荟萃分析。膳食碳水化合物、脂肪和蛋白质摄入量的汇总统计数据来自英国生物银行。采用反方差加权、加权中位数和Egger回归模型评估孟德尔随机化关联,以增强稳健性。对重要代谢物进行富集分析,以确定相关的代谢途径。相关性以95%置信区间的比值比表示,并使用富集分析根据p值确定关键的KEGG通路。结果:孟德尔随机分析确定了540种代谢物-常量营养素相关:186种与碳水化合物摄入有关,217种与脂肪摄入有关,137种与蛋白质摄入有关。代谢产物与碳水化合物和蛋白质摄入呈负相关,但与脂肪摄入呈正相关,在KEGG途径中富集,特别是那些控制芳香氨基酸(色氨酸和苯丙氨酸)和支链氨基酸(酪氨酸、缬氨酸、亮氨酸和异亮氨酸)的生物合成和代谢的代谢产物。结论:本研究利用广泛的遗传数据,全面绘制了代谢物与膳食宏量营养素摄入量的关系。这些发现强调了芳香和支链氨基酸的生物合成和代谢在宏量营养素调节中的重要作用。
{"title":"Metabolomic Markers for Dietary Carbohydrate, Fat, and Protein Consumption: A Two-Sample Mendelian Randomization Study.","authors":"Tung Hoang, Jeongseon Kim","doi":"10.1159/000548523","DOIUrl":"10.1159/000548523","url":null,"abstract":"<p><strong>Introduction: </strong>Observational studies have raised questions regarding the comprehensive metabolomic markers associated with dietary macronutrient intake. This study aimed to identify metabolites that are causally linked to dietary macronutrient consumption using a robust analytical framework.</p><p><strong>Methods: </strong>This genetic association study employed a two-sample Mendelian randomization (MR) approach. Genetic proxies for metabolites and their summary statistics were sourced from 64 genome-wide association studies, and a meta-analysis provided summary statistics for 3,362 metabolites. Summary statistics for dietary carbohydrate, fat, and protein intakes were obtained from the UK Biobank. MR associations were assessed using inverse-variance weighted, weighted median, and Egger's regression models to enhance robustness. Significant metabolites were subjected to enrichment analysis to identify relevant metabolic pathways. Associations were expressed as odds ratios with 95% confidence intervals, and enrichment analysis was used to identify key KEGG pathways based on p values.</p><p><strong>Results: </strong>MR analysis identified 540 metabolite-macronutrient associations: 186 for carbohydrate intake, 217 for fat intake, and 137 for protein intake. Metabolites inversely associated with carbohydrate and protein intake, but positively linked to fat intake, were enriched in KEGG pathways, particularly those governing the biosynthesis and metabolism of aromatic amino acids (tryptophan and phenylalanine) and branched-chain amino acids (BCAAs) (tyrosine, valine, leucine, and isoleucine).</p><p><strong>Conclusion: </strong>This study comprehensively mapped the metabolite associations with dietary macronutrient intake using extensive genetic data. These findings highlight the critical roles of aromatic and BCAA biosynthesis and metabolism as key metabolic pathways in macronutrient regulation.</p>","PeriodicalId":8269,"journal":{"name":"Annals of Nutrition and Metabolism","volume":" ","pages":"1-12"},"PeriodicalIF":2.9,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145224832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential Contribution of Plant-Based Milk Alternatives to the Nutrient Supply in Sustainable Diets. 植物性牛奶替代品对可持续饮食中营养供应的潜在贡献。
IF 2.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-09-25 DOI: 10.1159/000548487
Margrit Richter, Alessa Klug, Christina Breidenassel, Anne Carolin Schäfer, Johanna Conrad, Bernhard Watzl
{"title":"Potential Contribution of Plant-Based Milk Alternatives to the Nutrient Supply in Sustainable Diets.","authors":"Margrit Richter, Alessa Klug, Christina Breidenassel, Anne Carolin Schäfer, Johanna Conrad, Bernhard Watzl","doi":"10.1159/000548487","DOIUrl":"10.1159/000548487","url":null,"abstract":"","PeriodicalId":8269,"journal":{"name":"Annals of Nutrition and Metabolism","volume":" ","pages":"1-2"},"PeriodicalIF":2.9,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interactions between Total Energy, and Protein Intake, and the MC4R rs17782313 Variant on Lipid Levels in Saudi Adults: A Cross-Sectional Study. 沙特成年人总能量和蛋白质摄入与MC4R rs17782313变异对脂质水平的相互作用:一项横断面研究
IF 2.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-09-19 DOI: 10.1159/000548524
Israa M Shatwan, Maha S Al-Odinan, Najlaa M Aljefree, Noha M Almoraie, Basma Tariq Jamal, Marwan A Bakarman, Hani A Alhadrami

Introduction: Genetic variations, including rs17782313 (C/T) in the MC4R gene, are associated with lipid levels. Gene-diet interactions contribute to disease development. This study aimed to investigate the effects of interactions between total energy intake, protein intake, and MC4R rs17782313 on lipid parameters in Saudi adults.

Methods: In a cross-sectional study of 268 Saudi adults (aged 20-55 years), dietary data were assessed using a 136-item validated semiquantitative food frequency questionnaire, and MC4R (rs17782313) was genotyped using real-time polymerase chain reaction.

Results: Total energy and protein calorie intake interacted with the MC4R rs17782313 polymorphism to influence total cholesterol (TC) (pinteraction = 0.036 and pinteraction = 0.021, respectively). Low total energy and protein intake was associated with decreased TC levels in all genotypes at rs17782313. The interaction between total energy intake and MC4R rs17782313 affected triglyceride levels (pinteraction = 0.039). Protein calorie intake significantly interacted with MC4R rs17782313 in determining low-density lipoprotein (pinteraction = 0.042). However, none of these interactions remained significant after applying Bonferroni correction (p > 0.01).

Conclusion: Low total energy and protein intake is associated with low lipid levels among all genotypes at rs17782313 in Saudi adults. Further validation in larger cohorts is warranted to confirm these findings and explore their clinical implications.

遗传变异,包括MC4R基因中的rs17782313 (C/T),与血脂水平相关。基因-饮食相互作用有助于疾病的发展。本研究旨在探讨总能量摄入、蛋白质摄入和MC4R rs17782313之间的相互作用对沙特成年人脂质参数的影响。方法:在对268名沙特成年人(20-55岁)的横断面研究中,使用136项经验证的半定量食物频率问卷对饮食数据进行评估,并使用实时聚合酶链反应对MC4R (rs17782313)进行基因分型。结果:总能量和蛋白质热量摄入与MC4R rs17782313多态性相互作用,影响总胆固醇(TC) (P互作= 0.036,P互作=0.021)。总能量和蛋白质摄入量低与rs17782313所有基因型的TC水平降低有关。总能量摄入与MC4R rs17782313的交互作用影响甘油三酯水平(P交互作用=0.039)。蛋白质热量摄入与MC4R rs17782313在测定低密度脂蛋白方面存在显著交互作用(P交互作用= 0.042)。结论:在沙特成人rs17782313的所有基因型中,低总能量和蛋白质摄入与低脂水平相关。需要在更大的队列中进一步验证以证实这些发现并探索其临床意义。
{"title":"Interactions between Total Energy, and Protein Intake, and the MC4R rs17782313 Variant on Lipid Levels in Saudi Adults: A Cross-Sectional Study.","authors":"Israa M Shatwan, Maha S Al-Odinan, Najlaa M Aljefree, Noha M Almoraie, Basma Tariq Jamal, Marwan A Bakarman, Hani A Alhadrami","doi":"10.1159/000548524","DOIUrl":"10.1159/000548524","url":null,"abstract":"<p><strong>Introduction: </strong>Genetic variations, including rs17782313 (C/T) in the MC4R gene, are associated with lipid levels. Gene-diet interactions contribute to disease development. This study aimed to investigate the effects of interactions between total energy intake, protein intake, and MC4R rs17782313 on lipid parameters in Saudi adults.</p><p><strong>Methods: </strong>In a cross-sectional study of 268 Saudi adults (aged 20-55 years), dietary data were assessed using a 136-item validated semiquantitative food frequency questionnaire, and MC4R (rs17782313) was genotyped using real-time polymerase chain reaction.</p><p><strong>Results: </strong>Total energy and protein calorie intake interacted with the MC4R rs17782313 polymorphism to influence total cholesterol (TC) (p<sub>interaction</sub> = 0.036 and p<sub>interaction</sub> = 0.021, respectively). Low total energy and protein intake was associated with decreased TC levels in all genotypes at rs17782313. The interaction between total energy intake and MC4R rs17782313 affected triglyceride levels (p<sub>interaction</sub> = 0.039). Protein calorie intake significantly interacted with MC4R rs17782313 in determining low-density lipoprotein (p<sub>interaction</sub> = 0.042). However, none of these interactions remained significant after applying Bonferroni correction (p > 0.01).</p><p><strong>Conclusion: </strong>Low total energy and protein intake is associated with low lipid levels among all genotypes at rs17782313 in Saudi adults. Further validation in larger cohorts is warranted to confirm these findings and explore their clinical implications.</p>","PeriodicalId":8269,"journal":{"name":"Annals of Nutrition and Metabolism","volume":" ","pages":"1-9"},"PeriodicalIF":2.9,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ECONOMIC BURDEN OF OBESITY IN HUNGARY. 匈牙利肥胖的经济负担。
IF 2.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-09-15 DOI: 10.1159/000547338
Emese Antal, Péter Torzsa, Imre Rurik

Background: Obesity is a significant threat to national and global public health in terms of its prevalence and economic burden due to obesity-related complications (ORCs) and morbidities. The aim of this study is to calculate obesity-related public expenditures in Hungary in order to estimate the expenses and contribution of patients in 2019 and in 2022, before and after the COVID-19 pandemic, respectively.

Method: Expenditures related to patients with obesity, who suffered from more frequent co-morbidities, were requested from the national database of the National Health Insurance Fund. Financial information related to the inpatient and the outpatient providers and reimbursement for the prescription of medicines and healing aids was collected.

Results: Obesity-related morbidities represent 10-12 % of all cases in the public health care system. National public health care expenses were reported to be close to HUF 144 billion (EUR 444 million) for 2019 and HUF 133 billion (EUR 393 million) for 2022. These sums represent 7-11% of the total national spending for health care provision, not accounting for sick leave expenditures. The co-payment of patients was estimated to be around HUF 34 billion (EUR 104 million) for 2019 and HUF 43 billion (EUR 109 million) for 2022. Public expenditures and co-payments related to Type 2 diabetes and hypertension were the highest. Public and individual expenditures represent 0.3-0.4% of the GDP, which is equivalent to EUR 56 and EUR 52 per capita, respectively, for all inhabitants of the country.

Conclusion: Reducing these high expenses is possible through the introduction of appropriate education and public health policies to prevent obesity at an individual level and enable weight reduction among persons living with obesity. To calculate the cost of obesity, an international consensus on standardized methods is required to improve homogeneity and comparability.

背景:就肥胖相关并发症(ORCs)和发病率的患病率和经济负担而言,肥胖是对国家和全球公共卫生的重大威胁。本研究的目的是计算匈牙利与肥胖相关的公共支出,以估计2019年和2022年患者在2019冠状病毒病大流行之前和之后的费用和贡献。方法:从国民健康保险基金的国家数据库中查询与肥胖患者相关的支出,这些患者患有更频繁的合并症。收集了与住院和门诊提供者有关的财务信息以及药物处方和治疗辅助工具的报销。结果:在公共卫生保健系统中,肥胖相关的发病率占所有病例的10- 12%。据报道,2019年全国公共医疗费用接近1440亿福郎(4.44亿欧元),2022年接近1330亿福郎(3.93亿欧元)。这些金额占全国医疗保健总支出的7-11%,不包括病假支出。据估计,2019年患者共付额约为340亿福郎(1.04亿欧元),2022年约为430亿福郎(1.09亿欧元)。与2型糖尿病和高血压相关的公共支出和自付额最高。公共和个人支出占国内生产总值的0.3-0.4%,相当于全国所有居民人均支出分别为56欧元和52欧元。结论:通过引入适当的教育和公共卫生政策,在个人层面预防肥胖,并使肥胖患者减肥,可以减少这些高昂的费用。为了计算肥胖的成本,需要在标准化方法上达成国际共识,以提高同质性和可比性。
{"title":"ECONOMIC BURDEN OF OBESITY IN HUNGARY.","authors":"Emese Antal, Péter Torzsa, Imre Rurik","doi":"10.1159/000547338","DOIUrl":"https://doi.org/10.1159/000547338","url":null,"abstract":"<p><strong>Background: </strong>Obesity is a significant threat to national and global public health in terms of its prevalence and economic burden due to obesity-related complications (ORCs) and morbidities. The aim of this study is to calculate obesity-related public expenditures in Hungary in order to estimate the expenses and contribution of patients in 2019 and in 2022, before and after the COVID-19 pandemic, respectively.</p><p><strong>Method: </strong>Expenditures related to patients with obesity, who suffered from more frequent co-morbidities, were requested from the national database of the National Health Insurance Fund. Financial information related to the inpatient and the outpatient providers and reimbursement for the prescription of medicines and healing aids was collected.</p><p><strong>Results: </strong>Obesity-related morbidities represent 10-12 % of all cases in the public health care system. National public health care expenses were reported to be close to HUF 144 billion (EUR 444 million) for 2019 and HUF 133 billion (EUR 393 million) for 2022. These sums represent 7-11% of the total national spending for health care provision, not accounting for sick leave expenditures. The co-payment of patients was estimated to be around HUF 34 billion (EUR 104 million) for 2019 and HUF 43 billion (EUR 109 million) for 2022. Public expenditures and co-payments related to Type 2 diabetes and hypertension were the highest. Public and individual expenditures represent 0.3-0.4% of the GDP, which is equivalent to EUR 56 and EUR 52 per capita, respectively, for all inhabitants of the country.</p><p><strong>Conclusion: </strong>Reducing these high expenses is possible through the introduction of appropriate education and public health policies to prevent obesity at an individual level and enable weight reduction among persons living with obesity. To calculate the cost of obesity, an international consensus on standardized methods is required to improve homogeneity and comparability.</p>","PeriodicalId":8269,"journal":{"name":"Annals of Nutrition and Metabolism","volume":" ","pages":"1-18"},"PeriodicalIF":2.9,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145063305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin Profile of the Patients with Chronic Kidney Disease Receiving a Novel Total Parenteral Nutrition Formula: Multicenter Randomized Controlled Phase III Trial. 接受一种新型全肠外营养配方的慢性肾病患者的维生素概况:多中心随机对照III期试验
IF 2.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-09-04 DOI: 10.1159/000547656
Ken Tsuchiya, Tatsukuni Kawakami, Yusuke Maniwa, Yoshiyuki Kawauchi, Motofusa Katayama

Introduction: Efficacy and safety of a novel total parenteral nutrition formula for chronic kidney disease patients, OPF-109, containing multivitamins based on the FDA2000 recommendation were investigated.

Methods: We conducted a phase III clinical trial administering OPF-109 (n = 63) or the control solutions (combination of marketed products including multivitamin based on American Medical Association 1975 guidelines) (n = 61) to the chronic kidney disease patients for 8 days. Blood concentrations of proteins and vitamins and safety were evaluated. The primary efficacy endpoint was protein concentration (serum T-P, ALB, pre-ALB, transferrin) on day 8. Safety endpoints were hematological data, blood biochemistry data, vital signs, and adverse events.

Results: Values of blood protein until day 8 were similar in 2 groups although those of vitamins B1, B6, C, and folic acid (contained more in OPF-109) were higher in the OPF-109 group. For both groups, vitamin C concentration of day 1 was below the normal range, which restored to within the range in the OPF-109 group but decreased in the control group on day 8. Vitamin K concentration (contained less in OPF-109) was over the normal range on day 1 in both groups and decreased to slightly higher than the normal range in the OPF-109 group while increased to higher than day 1 value in the control group on day 8. Safety was similar in 2 groups.

Conclusion: Efficacy and safety of OPF-109 and usefulness of multivitamins based on the FDA2000 recommendation formula were confirmed in chronic kidney disease patients.

基于FDA2000推荐的一种新型含多种维生素的慢性肾病患者全肠外营养配方OPF-109的疗效和安全性进行了研究。方法:我们进行了一项III期临床试验,对慢性肾病患者给予OPF-109 (n=63)或对照溶液(根据美国医学协会1975年指南,包括多种维生素在内的上市产品组合)(n=61) 8天。评估血液中蛋白质和维生素的浓度及安全性。主要疗效终点为第8天的蛋白浓度(血清T-P、ALB、ALB前期、转铁蛋白)。安全性终点包括血液学数据、血液生化数据、生命体征和不良事件。结果:两组至第8天的血蛋白值相近,但OPF-109组的维生素B1、B6、C和叶酸含量较高(OPF-109中含有较多叶酸)。两组维生素C浓度在第1天均低于正常范围,OPF-109组维生素C浓度在第8天恢复到正常范围内,对照组维生素C浓度下降。两组维生素K浓度(OPF-109中含量较少)在第1天均超过正常范围,OPF-109组维生素K浓度在第8天下降至略高于正常范围,而对照组维生素K浓度在第8天上升至高于正常范围。两组的安全性相似。结论:OPF-109在慢性肾病患者中的有效性和安全性以及基于FDA 2000推荐配方的复合维生素的有效性得到了证实。
{"title":"Vitamin Profile of the Patients with Chronic Kidney Disease Receiving a Novel Total Parenteral Nutrition Formula: Multicenter Randomized Controlled Phase III Trial.","authors":"Ken Tsuchiya, Tatsukuni Kawakami, Yusuke Maniwa, Yoshiyuki Kawauchi, Motofusa Katayama","doi":"10.1159/000547656","DOIUrl":"10.1159/000547656","url":null,"abstract":"<p><strong>Introduction: </strong>Efficacy and safety of a novel total parenteral nutrition formula for chronic kidney disease patients, OPF-109, containing multivitamins based on the FDA2000 recommendation were investigated.</p><p><strong>Methods: </strong>We conducted a phase III clinical trial administering OPF-109 (n = 63) or the control solutions (combination of marketed products including multivitamin based on American Medical Association 1975 guidelines) (n = 61) to the chronic kidney disease patients for 8 days. Blood concentrations of proteins and vitamins and safety were evaluated. The primary efficacy endpoint was protein concentration (serum T-P, ALB, pre-ALB, transferrin) on day 8. Safety endpoints were hematological data, blood biochemistry data, vital signs, and adverse events.</p><p><strong>Results: </strong>Values of blood protein until day 8 were similar in 2 groups although those of vitamins B1, B6, C, and folic acid (contained more in OPF-109) were higher in the OPF-109 group. For both groups, vitamin C concentration of day 1 was below the normal range, which restored to within the range in the OPF-109 group but decreased in the control group on day 8. Vitamin K concentration (contained less in OPF-109) was over the normal range on day 1 in both groups and decreased to slightly higher than the normal range in the OPF-109 group while increased to higher than day 1 value in the control group on day 8. Safety was similar in 2 groups.</p><p><strong>Conclusion: </strong>Efficacy and safety of OPF-109 and usefulness of multivitamins based on the FDA2000 recommendation formula were confirmed in chronic kidney disease patients.</p>","PeriodicalId":8269,"journal":{"name":"Annals of Nutrition and Metabolism","volume":" ","pages":"1-15"},"PeriodicalIF":2.9,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144999569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Economic Dimension of Childhood Obesity: Costs and Potential of New Anti-Obesity Medications. 儿童肥胖的经济维度:新的抗肥胖药物的成本和潜力。
IF 3.2 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-05-08 DOI: 10.1159/000546140
Julian Gomahr, Julia Lischka, Caroline Braet, Marie-Laure Frelut, Teodora Handjieva-Darlenska, Edyta Łuszczki, Dénes Molnár, David Thivel, Gabriel Torbahn, Susanne Ring-Dimitriou, Andrea Vania, Elpis Vlachopapadopoulou, Daniel Weghuber
{"title":"The Economic Dimension of Childhood Obesity: Costs and Potential of New Anti-Obesity Medications.","authors":"Julian Gomahr, Julia Lischka, Caroline Braet, Marie-Laure Frelut, Teodora Handjieva-Darlenska, Edyta Łuszczki, Dénes Molnár, David Thivel, Gabriel Torbahn, Susanne Ring-Dimitriou, Andrea Vania, Elpis Vlachopapadopoulou, Daniel Weghuber","doi":"10.1159/000546140","DOIUrl":"10.1159/000546140","url":null,"abstract":"","PeriodicalId":8269,"journal":{"name":"Annals of Nutrition and Metabolism","volume":" ","pages":"1-3"},"PeriodicalIF":3.2,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143967313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preface. 前言。
IF 3.2 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-04-10 DOI: 10.1159/000540495
Flavia Indrio, Hania Szajewska
{"title":"Preface.","authors":"Flavia Indrio, Hania Szajewska","doi":"10.1159/000540495","DOIUrl":"https://doi.org/10.1159/000540495","url":null,"abstract":"","PeriodicalId":8269,"journal":{"name":"Annals of Nutrition and Metabolism","volume":" ","pages":"1-2"},"PeriodicalIF":3.2,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143972421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Economic Burden of Obesity in Children and Adolescents in Austria. 奥地利儿童和青少年肥胖的经济负担。
IF 3.2 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-03-21 DOI: 10.1159/000545082
Stephanie Reitzinger, Thomas Czypionka

Introduction: In Europe, one in three school-aged children live with overweight or obesity and are at high risk of continuing to be affected by it throughout their lives. The objective of our study was to quantify the economic burden of obesity among Austrian children and adolescents born between 2000 and 2019.

Methods: We used obesity projections and the share of young adults assumed to have remained with obesity since childhood or adolescence to project the lifetime costs of birth cohorts from 2000 to 2019. We estimated lifetime costs per individual using population-attributable fractions, considering a discount rate of 3%, obesity-associated mortality, an obesity-associated "income penalty," and future cost increases in the healthcare system.

Results: For Austria, we estimated that around 95,000 of all children and adolescents in 2019 remain with obesity as adults, which leads to a present value of EUR 9.2 billion or an annuity of approximately EUR 285 million (0.07% of GDP in 2019). Approximately 15% of costs arise from direct costs and 85% from indirect costs.

Conclusion: We highlighted the long-term economic burden of early-onset obesity in Austria and concluded that public health programs addressing children and adolescents with obesity could relieve high costs not only for individuals but also for society.

导读:在欧洲,三分之一的学龄儿童生活在超重或肥胖的环境中,并且很有可能终生受其影响。方法:我们使用人口预测和自童年或青春期以来一直肥胖的年轻人的比例来预测2000年至2019年出生队列的终生成本。考虑到3%的贴现率、肥胖相关的死亡率、肥胖相关的“收入惩罚”和未来医疗保健系统的成本增加,我们使用人口归因分数来估计每个人的终身成本。结果:对于奥地利,我们估计2019年约有95,000名儿童和青少年将在成年后保持肥胖,这将导致92亿欧元的现值或约2.85亿欧元的年金(占2019年GDP的0.07%)。大约15%的成本来自直接成本,85%来自间接成本。结论:我们强调了奥地利早发性肥胖的长期经济负担,并得出结论,针对儿童和青少年肥胖的公共卫生计划不仅可以减轻个人的高成本,也可以减轻社会的高成本。
{"title":"The Economic Burden of Obesity in Children and Adolescents in Austria.","authors":"Stephanie Reitzinger, Thomas Czypionka","doi":"10.1159/000545082","DOIUrl":"10.1159/000545082","url":null,"abstract":"<p><strong>Introduction: </strong>In Europe, one in three school-aged children live with overweight or obesity and are at high risk of continuing to be affected by it throughout their lives. The objective of our study was to quantify the economic burden of obesity among Austrian children and adolescents born between 2000 and 2019.</p><p><strong>Methods: </strong>We used obesity projections and the share of young adults assumed to have remained with obesity since childhood or adolescence to project the lifetime costs of birth cohorts from 2000 to 2019. We estimated lifetime costs per individual using population-attributable fractions, considering a discount rate of 3%, obesity-associated mortality, an obesity-associated \"income penalty,\" and future cost increases in the healthcare system.</p><p><strong>Results: </strong>For Austria, we estimated that around 95,000 of all children and adolescents in 2019 remain with obesity as adults, which leads to a present value of EUR 9.2 billion or an annuity of approximately EUR 285 million (0.07% of GDP in 2019). Approximately 15% of costs arise from direct costs and 85% from indirect costs.</p><p><strong>Conclusion: </strong>We highlighted the long-term economic burden of early-onset obesity in Austria and concluded that public health programs addressing children and adolescents with obesity could relieve high costs not only for individuals but also for society.</p>","PeriodicalId":8269,"journal":{"name":"Annals of Nutrition and Metabolism","volume":" ","pages":"1-7"},"PeriodicalIF":3.2,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prehabilitation: Do We Need Metabolic Flexibility? 预适应-我们需要代谢灵活性吗?
IF 2.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-01 Epub Date: 2025-03-21 DOI: 10.1159/000545266
Nicholas Tetlow, John Whittle

Background: Metabolic flexibility, the capacity to switch between energy sources in response to changing physiological demands, emerges as a critical determinant of perioperative resilience. In the context of surgery, where metabolic demands are high and energy homeostasis is disrupted, patients with metabolic inflexibility may experience worse outcomes due to impaired immune responses and heightened insulin resistance, resulting in prolonged recovery times.

Summary: This article explores the implications of metabolic flexibility in the perioperative period and examines the potential for prehabilitation strategies, such as targeted exercise and nutritional interventions, to improve patient readiness for surgery. Cardiopulmonary exercise testing is discussed as a valuable assessment tool for metabolic flexibility, capable of providing insights into a patient's fuel adaptability and overall metabolic health preoperatively. Evidence suggests that targeted exercise and nutritional strategies can enhance mitochondrial function, improve nutrient-sensing pathways, and increase substrate oxidation, which may reduce perioperative complications and support immune resilience.

Key messages: Future research should prioritise refining methods to identify metabolically inflexible patients and tailoring prehabilitation interventions to optimise metabolic flexibility. Enhancing perioperative metabolic readiness is important for populations vulnerable to metabolic dysfunction, such as those with obesity, diabetes, and cancer. Aligning metabolic optimisation with surgical recovery demands may help establish new standards in perioperative care and improve patient outcomes.

代谢灵活性,即根据生理需求的变化在能量来源之间切换的能力,是围手术期恢复能力的关键决定因素。在外科手术中,代谢需求高,能量稳态被破坏,代谢不灵活的患者可能会由于免疫反应受损和胰岛素抵抗升高而经历更糟糕的结果,导致恢复时间延长。本文探讨了围手术期代谢灵活性的影响,并探讨了潜在的康复策略,如有针对性的运动和营养干预,以提高患者对手术的准备。心肺运动测试(CPET)作为一种有价值的代谢灵活性评估工具进行了讨论,能够提供患者术前燃料适应性和整体代谢健康的见解。有证据表明,有针对性的运动和营养策略可以增强线粒体功能,改善营养感应途径,增加底物氧化,从而可能减少围手术期并发症并支持免疫恢复能力。未来的研究应侧重于改进方法,以识别代谢不灵活的患者,并定制康复干预措施,以优化代谢灵活性,特别是在易受代谢功能障碍影响的人群中,如肥胖、糖尿病和癌症患者。这种方法可以通过将代谢准备与手术恢复需求结合起来,建立围手术期护理的新标准。
{"title":"Prehabilitation: Do We Need Metabolic Flexibility?","authors":"Nicholas Tetlow, John Whittle","doi":"10.1159/000545266","DOIUrl":"10.1159/000545266","url":null,"abstract":"<p><strong>Background: </strong>Metabolic flexibility, the capacity to switch between energy sources in response to changing physiological demands, emerges as a critical determinant of perioperative resilience. In the context of surgery, where metabolic demands are high and energy homeostasis is disrupted, patients with metabolic inflexibility may experience worse outcomes due to impaired immune responses and heightened insulin resistance, resulting in prolonged recovery times.</p><p><strong>Summary: </strong>This article explores the implications of metabolic flexibility in the perioperative period and examines the potential for prehabilitation strategies, such as targeted exercise and nutritional interventions, to improve patient readiness for surgery. Cardiopulmonary exercise testing is discussed as a valuable assessment tool for metabolic flexibility, capable of providing insights into a patient's fuel adaptability and overall metabolic health preoperatively. Evidence suggests that targeted exercise and nutritional strategies can enhance mitochondrial function, improve nutrient-sensing pathways, and increase substrate oxidation, which may reduce perioperative complications and support immune resilience.</p><p><strong>Key messages: </strong>Future research should prioritise refining methods to identify metabolically inflexible patients and tailoring prehabilitation interventions to optimise metabolic flexibility. Enhancing perioperative metabolic readiness is important for populations vulnerable to metabolic dysfunction, such as those with obesity, diabetes, and cancer. Aligning metabolic optimisation with surgical recovery demands may help establish new standards in perioperative care and improve patient outcomes.</p>","PeriodicalId":8269,"journal":{"name":"Annals of Nutrition and Metabolism","volume":" ","pages":"223-233"},"PeriodicalIF":2.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12060803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143690954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do Global Infant Feeding Policies Respect the United Nations Principles on the Rights of Children and Families? 全球婴儿喂养政策是否尊重联合国关于儿童和家庭权利的原则?
IF 2.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-01 Epub Date: 2025-04-23 DOI: 10.1159/000546054
Stewart Forsyth

Background: Under the terms of the United Nations Convention on the Rights of the Child (UNCRC), governments are now required to enable all children to fulfil their full potential with the key principles being non-discrimination, the right to life and development, the best interests of the child, and the right to be heard. A recent statement by UNICEF indicated that implementation of the principles of the UNCRC provide a pathway for WHO, WHA, and UNICEF global infant feeding policy documents to be introduced into domestic law. But these documents are not recent and have not been updated, and they represent high levels of non-compliance. Moreover, do they actually comply with the principles set out in the UNCRC?

Summary: Global decisions on infant feeding are being made by organisations who are distant from family circumstances and primarily reflect the views of WHO/UNICEF and activist groups. Evidence of dismissal of public consultation is discriminatory, and an unwillingness to manage differences of opinion is a denial of the right to be heard.

Key message: National governments can serve the best interests of the child through sovereign rights, national responsibility and accountability, and development of national infant feeding policies that reflect UNCRC principles.

根据《联合国儿童权利公约》(儿童权利公约)的精神,儿童基金会指出,卫生组织/卫生大会/儿童基金会的婴儿喂养政策文件现在应纳入国内法。令人关切的是,这些文件不是最近的,也没有更新,有很大程度的不遵守情况,为了确定它们是否适合作为卫生政策、立法文书或符合《公约》所载原则的例子,需要对它们进行正式审查,然后才能在法庭上视为适当的证据。本文强调了正式审查可能产生的问题,因为婴儿喂养政策制定是一个高度竞争的环境,几个相互关联的因素可能对婴儿及其父母的合法权利产生负面影响。结论是,《儿童权利公约》所赞同的原则显然是针对各国政府的,这应继续成为主要焦点。重要的是,《儿童权利公约》批准的相关政策不能有效地满足人口的保健需要,也不能满足婴儿及其家庭的权利,因此不能损害这些原则的可信度。
{"title":"Do Global Infant Feeding Policies Respect the United Nations Principles on the Rights of Children and Families?","authors":"Stewart Forsyth","doi":"10.1159/000546054","DOIUrl":"10.1159/000546054","url":null,"abstract":"<p><strong>Background: </strong>Under the terms of the United Nations Convention on the Rights of the Child (UNCRC), governments are now required to enable all children to fulfil their full potential with the key principles being non-discrimination, the right to life and development, the best interests of the child, and the right to be heard. A recent statement by UNICEF indicated that implementation of the principles of the UNCRC provide a pathway for WHO, WHA, and UNICEF global infant feeding policy documents to be introduced into domestic law. But these documents are not recent and have not been updated, and they represent high levels of non-compliance. Moreover, do they actually comply with the principles set out in the UNCRC?</p><p><strong>Summary: </strong>Global decisions on infant feeding are being made by organisations who are distant from family circumstances and primarily reflect the views of WHO/UNICEF and activist groups. Evidence of dismissal of public consultation is discriminatory, and an unwillingness to manage differences of opinion is a denial of the right to be heard.</p><p><strong>Key message: </strong>National governments can serve the best interests of the child through sovereign rights, national responsibility and accountability, and development of national infant feeding policies that reflect UNCRC principles.</p>","PeriodicalId":8269,"journal":{"name":"Annals of Nutrition and Metabolism","volume":" ","pages":"245-249"},"PeriodicalIF":2.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12136522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143964838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Nutrition and Metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1